|
1
|
Ginter E and Simko V: Global prevalence
and future of diabetes mellitus. Adv Exp Med Biol. 771:35–41.
2012.PubMed/NCBI
|
|
2
|
Willard AL and Herman IM: Vascular
complications and diabetes: Current therapies and future
challenges. J Ophthalmol. 2012:2095382012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kowluru RA and Chan PS: Oxidative stress
and diabetic retinopathy. Exp Diabetes Res. 2007:436032007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Witmer AN, Vrensen GF, Van Noorden CJ and
Schlingemann RO: Vascular endothelial growth factors and
angiogenesis in eye disease. Prog Retin Eye Res. 22:1–29. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abu E, l-Asrar AM, Nawaz MI, Kangave D,
Siddiquei M Mairaj and Geboes K: Angiogenic and vasculogenic
factors in the vitreous from patients with proliferative diabetic
retinopathy. J Diabetes Res. 2013:5396582013.PubMed/NCBI
|
|
6
|
Kalka C, Masuda H, Takahashi T, Gordon R,
Tepper O, Gravereaux E, Pieczek A, Iwaguro H, Hayashi SI, Isner JM
and Asahara T: Vascular endothelial growth factor(165) gene
transfer augments circulating endothelial progenitor cells in human
subjects. Circ Res. 86:1198–1202. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li B, Sharpe EE, Maupin AB, Teleron AA,
Pyle AL, Carmeliet P and Young PP: VEGF and PlGF promote adult
vasculogenesis by enhancing EPC recruitment and vessel formation at
the site of tumor neovascularization. FASEB J. 20:1495–1497. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aiello LP, Avery RL, Arrigg PG, Keyt BA,
Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, et
al: Vascular endothelial growth factor in ocular fluid of patients
with diabetic retinopathy and other retinal disorders. N Engl J
Med. 331:1480–1487. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang X, Wang G and Wang Y: Intravitreous
vascular endothelial growth factor and hypoxia-inducible factor 1a
in patients with proliferative diabetic retinopathy. Am J
Ophthalmol. 148:883–889. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Matsuoka M, Ogata N, Minamino K and
Matsumura M: Expression of pigment epithelium-derived factor and
vascular endothelial growth factor in fibrovascular membranes from
patients with proliferative diabetic retinopathy. Jpn J Ophthalmol.
50:116–120. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Abu E, l-Asrar AM, Missotten L and Geboes
K: Expression of hypoxia-inducible factor-1alpha and the protein
products of its target genes in diabetic fibrovascular epiretinal
membranes. Br J Ophthalmol. 91:822–826. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lim JI, Spee C and Hinton DR: A comparison
of hypoxia-inducible factor-α in surgically excised neovascular
membranes of patients with diabetes compared with idiopathic
epiretinal membranes in nondiabetic patients. Retina. 30:1472–1478.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chung EJ, Kang SJ, Koo JS, Choi YJ,
Grossniklaus HE and Koh HJ: Effect of intravitreal bevacizumab on
vascular endothelial growth factor expression in patients with
proliferative diabetic retinopathy. Yonsei Med J. 52:151–157. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shibuya M: Differential roles of vascular
endothelial growth factor receptor-1 and receptor-2 in
angiogenesis. J Biochem Mol Biol. 39:469–478. 2006.PubMed/NCBI
|
|
15
|
Hubbard AK and Rothlein R: Intercellular
adhesion molecule-1 (ICAM-1) expression and cell signaling
cascades. Free Radic Biol Med. 28:1379–1386. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Barouch FC, Miyamoto K, Allport JR, Fujita
K, Bursell SE, Aiello LP, Luscinskas FW and Adamis AP:
Integrin-mediated neutrophil adhesion and retinal leukostasis in
diabetes. Invest Ophthalmol Vis Sci. 41:1153–1158. 2000.PubMed/NCBI
|
|
17
|
Zhou L, Zuo Z and Chow MS: Danshen: An
overview of its chemistry, pharmacology, pharmacokinetics, and
clinical use. J Clin Pharmacol. 45:1345–1359. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gong Z, Huang C, Sheng X, Zhang Y, Li Q,
Wang MW, Peng L and Zang YQ: The role of tanshinone IIA in the
treatment of obesity through peroxisome proliferator-activated
receptor gamma antagonism. Endocrinology. 150:104–113. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hwang SL, Yang JH, Jeong YT, Kim YD, Li X,
Lu Y, Chang YC, Son KH and Chang HW: Tanshinone IIA improves
endoplasmic reticulum stress-induced insulin resistance through
AMP-activated protein kinase. Biochem Biophys Res Commun.
430:1246–1252. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y, Wei L, Sun D, Cao F, Gao H, Zhao
L, Du J, Li Y and Wang H: Tanshinone IIA pretreatment protects
myocardium against ischaemia/reperfusion injury through the
phosphatidylinositol 3-kinase/Akt-dependent pathway in diabetic
rats. Diabetes Obes Metab. 12:316–322. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Du JR, Yu Y, Bai B and Zheng XY:
Tanshinone IIA inhibits smooth muscle proliferation and intimal
hyperplasia in the rat carotid balloon-injured model through
inhibition of MAPK signaling pathway. J Ethnopharmacol.
129:273–279. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Z, Liu G, Xiao Y and Lu P:
Adrenomedullin22-52 suppresses high-glucose-induced migration,
proliferation, and tube formation of human retinal endothelial
cells. Mol Vis. 20:259–269. 2014.PubMed/NCBI
|
|
23
|
Dai C, Liu G, Li L, Xiao Y, Zhang X and Lu
P: ADP-ribosylation factor as a novel target for corneal
neovascularization regression. Mol Vis. 18:2947–2953.
2012.PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rajah TT and Grammas P: VEGF and VEGF
receptor levels in retinal and brain-derived endothelial cells.
Biochem Biophys Res Commun. 293:710–713. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Stitt AW, McGoldrick C, Rice-McCaldin A,
McCance DR, Glenn JV, Hsu DK, Liu FT, Thorpe SR and Gardiner TA:
Impaired retinal angiogenesis in diabetes: Role of advanced
glycation end products and galectin-3. Diabetes. 54:785–794. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dagher Z, Park YS, Asnaghi V, Hoehn T,
Gerhardinger C and Lorenzi M: Studies of rat and human retinas
predict a role for the polyol pathway in human diabetic
retinopathy. Diabetes. 53:2404–2411. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yuan L, Hu J, Luo Y, Liu Q, Li T, Parish
CR, Freeman C, Zhu X, Ma W, Hu X, et al: Upregulation of heparanase
in high-glucose-treated endothelial cells promotes endothelial cell
migration and proliferation and correlates with Akt and
extracellular-signal-regulated kinase phosphorylation. Mol Vis.
18:1684–1695. 2012.PubMed/NCBI
|
|
29
|
Premanand C, Rema M, Sameer MZ, Sujatha M
and Balasubramanyam M: Effect of curcumin on proliferation of human
retinal endothelial cells under in vitro conditions. Invest
Ophthalmol Vis Sci. 47:2179–2184. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shang Q, Xu H and Huang L: Tanshinone IIA:
A promising natural cardioprotective agent. Evid Based Complement
Alternat Med. 2012:7164592012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jeganathan VS: Anti-angiogenesis drugs in
diabetic retinopathy. Curr Pharm Biotechnol. 12:369–372. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kumar B, Gupta SK, Saxena R and Srivastava
S: Current trends in the pharmacotherapy of diabetic retinopathy. J
Postgrad Med. 58:132–139. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zechmeister-Koss I and Huic M: Vascular
endothelial growth factor inhibitors (anti-VEGF) in the management
of diabetic macular oedema: A systematic review. Br J Ophthalmol.
96:167–178. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Titchenell PM and Antonetti DA: Using the
past to inform the future: Anti-VEGF therapy as a road map to
develop novel therapies for diabetic retinopathy. Diabetes.
62:1808–1815. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stewart MW: Critical appraisal of
ranibizumab in the treatment of diabetic macular edema. Clin
Ophthalmol. 7:1257–1267. 2013. View Article : Google Scholar : PubMed/NCBI
|
